Haematological malignancy
RecruitingLong-term Follow-up Study for Patients with Solid and Blood Cancers Treated with Brexucabtagene Autoleucel or Axicabtagene Ciloleucel
Long-term Follow-up Study for Patients with Solid and Blood Cancers Treated with Brexucabtagene Autoleucel or Axicabtagene Ciloleucel
- Disease:Haematological malignancy
- Substances:Axicabtagene CiloleucelBrexucabtagene Autoleucel
Austria- Participants:0–17 years · 18–64 years · 65+ years
- Substances:Axicabtagene Ciloleucel
- Sponsor:Kite Pharma Inc.











